Head to Head Analysis: Global Medical REIT (GMRE) versus Its Rivals
Global Medical REIT (NYSE: GMRE) is one of 23 publicly-traded companies in the “Healthcare REITs” industry, but how does it contrast to its competitors? We will compare Global Medical REIT to similar businesses based on the strength of its risk, profitability, analyst recommendations, institutional ownership, valuation, dividends and earnings.
Earnings & Valuation
This table compares Global Medical REIT and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Global Medical REIT||$8.21 million||-$6.35 million||-30.56|
|Global Medical REIT Competitors||$812.10 million||$208.81 million||125.13|
Institutional & Insider Ownership
41.0% of Global Medical REIT shares are owned by institutional investors. Comparatively, 83.1% of shares of all “Healthcare REITs” companies are owned by institutional investors. 16.5% of Global Medical REIT shares are owned by insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Global Medical REIT has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Global Medical REIT’s competitors have a beta of 0.43, indicating that their average share price is 57% less volatile than the S&P 500.
Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.7%. Global Medical REIT pays out -296.3% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.4% and pay out 133.5% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.
This is a summary of recent ratings and price targets for Global Medical REIT and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Medical REIT||0||1||5||0||2.83|
|Global Medical REIT Competitors||142||757||681||12||2.35|
Global Medical REIT presently has a consensus price target of $10.75, suggesting a potential upside of 30.30%. As a group, “Healthcare REITs” companies have a potential upside of 5.10%. Given Global Medical REIT’s stronger consensus rating and higher probable upside, research analysts clearly believe Global Medical REIT is more favorable than its competitors.
This table compares Global Medical REIT and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Medical REIT||-19.98%||-2.86%||-1.39%|
|Global Medical REIT Competitors||35.60%||7.69%||3.77%|
Global Medical REIT competitors beat Global Medical REIT on 9 of the 15 factors compared.
About Global Medical REIT
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.